Skip Navigation Links
 Home 
 Registration 
 Pre Registered 
  
 Personal page 
 Archive 
Scroll up
Scroll down
-
-
Scroll up
Scroll down
               
Skip Navigation Links
        صفحه اصلی
        ساختار همایش
        مکان برگزاری
        ثبت نام
        ثبت نام شدگان
         مقالات
        مقالات پذیرفته شده
        برنامه همایش
        تماس با ما
        صفحه شخصی
        جستجوی سخنران
        آرشیو سمينار سالهای گذشته
 
مقاله Abstract


Title: Closantel; A veterinary drug with potential severe morbidity in humans
Author(s): Seyed Ali Tabatabaei, Mohammad Soleimani, Ahmad Mirshahi, Mjtaba Abrishami, Bahman Inanlo
Presentation Type: Poster
Subject: Retina and Retinal Cell Biology
Others:
Presenting Author:
Name: Ali Tabatabaei
Affiliation :(optional) Farabi Eye Hospital
E mail: alitabatabaei77@yahoo.com
Phone:
Mobile: 09121063062
Purpose:

To present an unusual case of blindness after taking a veterinary drug

Methods:

A 34-year-old depressed mood man was referred with progressive loss of vision in both eyes following inadvertently ingestion of three 500 mg tablets of Closantel. On fundus examination, left optic disc margin was blurred.

Results:

His bilateral light perception visual acuity showed no response to I.V. erythropoietin 20000 units daily for three days and 1gr intravenous methylprednisolone acetate for three days followed by 1mg/kg oral prednisolone for two weeks. On macular optical coherence tomography (OCT), a disruption in photoreceptors layer in outer retina was seen.

Conclusion:

Destruction of neurosensory retina and visual pathways is related to severe visual loss. This case alerts us about the destructive effect of this drug on humans even in low dosage that necessitates preventive efforts for this morbid side effect.

Attachment:





Last News

  -